Charles T. Maroney
Nessuna posizione attualmente
Profilo
Charles T.
Maroney is the founder of Prograft Medical, Inc. He previously worked as the President, Chief Executive Officer & Director of Cardiva Medical, Inc. from 2010 to 2015.
Prior to that, he was the President & Chief Executive Officer of Coalescent Surgical, Inc. and the Chief Executive Officer of CardioMind, Inc. He also worked as a Director at Benvenue Medical, Inc. and as a Principal at Target Therapeutics, Inc. Maroney holds a graduate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Precedenti posizioni note di Charles T. Maroney
| Società | Posizione | Fine |
|---|---|---|
Coalescent Surgical, Inc.
 Coalescent Surgical, Inc. Medical SpecialtiesHealth Technology Coalescent Surgica, Inc. is developing advanced technology for blood vessel anastomoses | Amministratore Delegato | 10/05/2005 |
Target Therapeutics, Inc.
 Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
| Prograft Medical, Inc. | Amministratore Delegato | - |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Amministratore Delegato | 24/02/2015 |
Benvenue Medical, Inc.
 Benvenue Medical, Inc. Medical SpecialtiesHealth Technology Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA. | Direttore/Membro del Consiglio | - |
Formazione di Charles T. Maroney
| Stanford University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
Benvenue Medical, Inc.
Benvenue Medical, Inc. Medical SpecialtiesHealth Technology Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA. | Health Technology |
CardioMind, Inc.
 CardioMind, Inc. Medical SpecialtiesHealth Technology CardioMind, Inc. manufactures therapeutic devices for cardiovascular diseases. It offers stent delivery systems, which are designed for the use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. The company was founded by Julian Nikolchev in 2003 and is headquartered in Sunnyvale, CA. | Health Technology |
Coalescent Surgical, Inc.
Coalescent Surgical, Inc. Medical SpecialtiesHealth Technology Coalescent Surgica, Inc. is developing advanced technology for blood vessel anastomoses | Health Technology |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Health Technology |
| Prograft Medical, Inc. |
- Borsa valori
- Insiders
- Charles T. Maroney
